Delaware, USA, 05 December 2023 – Omniscope Inc. today announced that it is presenting at Biotech Showcase™ 2024. This year, registered attendees can view Omniscope's presentation live, and also access a recorded version beginning November 27th – six weeks prior to the actual event.  With 24x7 on-demand access, attendees can view recorded presentations at their convenience when scheduling does not allow viewing during the main event week.

Vijay Vaswani, Co-founder and CEO, will be presenting Omniscope at Biotech Showcase.‍

09 January 2024, 0930hrs EST
Omniscope is building the world's largest and most complete immune databank, with high-resolution obtained through proprietary immune cell sequencing and AI. Vijay Vaswani will present on how the company's vertically-integrated platform powers groundbreaking therapeutic designs and diagnostic development.‍

"We are thrilled to once again be part of Biotech Showcase during JPM Week, a cornerstone event for our innovative journey. As we enter our third year of attendance, we remain steadfast in our commitment to pushing the boundaries of biotechnology and will be opening an Early Access Program for a new suite of products. Our presence here symbolizes not just our growth but our unwavering dedication to advancing healthcare solutions. We look forward to sharing our latest breakthroughs and fostering collaborations that will shape the future of biotech." -- Vijay Vaswani, Omniscope Co-founder and CEO.

Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year in San Francisco during the course of one of the industry's largest gatherings and busiest weeks.

“We are delighted that Omniscope will be joining us in San Francisco and presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime opportunity for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”

‍
_{ABOUT BIOTECH SHOWCASE
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 16th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.}

_{ABOUT OMNISCOPE
Omniscope is a techbio startup decoding the immune system in high-resolution through the convergence of proprietary immune cell sequencing and artificial intelligence. The company is building the world's largest and most complete immune databank, with high-resolution obtained through proprietary immune cell sequencing and AI. Its vertically-integrated platform powers groundbreaking therapeutic designs and diagnostic development. Founded in 2021, Omniscope has been revenue-generating since 2022 with early adopters including pharma, established academia, biotech and clinical research. The company is currently raising Series. Omniscope is powered by FoundersX Ventures and Google, and grants by the European Commission. Omniscope is a Delaware Inc. with operations in Spain.}